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Tuesday, March 8, 2011 465aresults obtained for backdoor phosphorylation of the enzyme in the presence of
Pb2þ ions.
In conclusion, we demonstrate that Pb2þ bound to the enzyme stabilizes an E2-
type conformation. In particular, under conditions that promote enzyme phos-
phorylation, Pb2þ ions are able to confine the Naþ,Kþ-ATPase into a phosphor-
ylated E2 state (4).
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The Mechanism of Bacterial Cuþ-ATPases. Distinct Efflux Rates Adapted
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Chemistry and Biochemistry Department, Worcester Polytechnic Institute,
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Copper plays important physiological roles as a protein co-factor. In bacteria,
cytoplasmic copper homeostasis is controlled by P1B-1-type Cu
þ-ATPases.
These highly homologous transporters share a common structure and the
classical Albers-Post (E1/E2) mechanism. It is accepted that most of these
enzymes drive cytoplasmic metal efflux and consequently confer Cuþ toler-
ance. Other members of this subfamily appear required for cuproprotein as-
sembly. Early studies using gene deletion, phenotypical characterization and
functional complementation, have suggested that these are in fact Cuþ im-
porters. To explain this phenotypical observation within the mechanistic con-
strains of the transport cycle of P-type ATPases, we have studied the Cuþ
transport by three proposed Cuþ importers: P. aeruginosa CopA2, E. hirae
CopA and Synechocystis PCC6803 CtaA. These were expressed in an
E. coli strain lacking its endogenous Cuþ-ATPase (DC194), functional
complementation was tested, and 64Cuþ transport into everted vesicles mea-
sured. These experiments show that all Cuþ- ATPases drive Cuþ efflux al-
though with quite different kinetics. ATPases involved in cuproprotein
assembly have much slower transport rates and high apparent metal affinities.
These characteristics explain phenotypes observed upon mutation of the cod-
ing genes.
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Charge Movement in Recombinant Copper ATPase is Investigated on
a Solid Supported Membrane
Francesco Tadini-Buoninsegni, Gianluca Bartolommei,
Maria Rosa Moncelli, Rajendra Pilankatta, David Lewis, Giuseppe Inesi.
The ATP7B copper ATPase is included in the P1-type ATPase subfamily,
which is selective for soft and transition metals. Its function is to deliver cop-
per to nascent metalloproteins and export excessive copper from the cell (1).
Biochemical characterization of this enzyme is hindered by its very low native
abundance and difficult detection of copper signal within the catalytic time
frame. We recently reported high yield heterologous expression of ATP7B
in COS-1 cells infected with adenovirus vector, and functional characteriza-
tion of membrane-bound ATPase obtained with the microsomal fraction of in-
fected cells (2). Here we show that the membrane-bound copper ATPase
obtained under the above-mentioned conditions is suited for adsorption on
a solid supported membrane and measurements of charge transfer. Using
this method, we detected charge movement within a single catalytic cycle
upon addition of ATP. We suggest that the observed charge movement is
due to displacement of bound copper, and it is related to formation of phos-
phoenzyme intermediate. ATP dependent charge movements, as well as phos-
phoenzyme formation, are totally prevented by single mutations of copper
binding sites.
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Genetic Incorporation of an Unnatural Fluorescent Amino Acid in a Plant
H-ATPase Expressed in Yeast
Bassem Gayed, Hyun Soo Lee, Michael G. Palmgren, Joshua R. Berlin.
Fluorescence labeling provides an important tool to study the structure and
function of proteins. Typically, fluorescence labeling involves either chemical
modification or protein fusion with fluorescent probes. These techniques, how-
ever, have several significant drawbacks. First, the degree to which fluorescent
probes interfere with protein folding and function is a concern. Second, many
protein domains are difficult to target specifically. In the particular case of in-
tegral membrane proteins, few fluorescent probes can be targeted specifically to
transmembrane domains without significantly disturbing protein function.
Thus, small fluorescent probes that minimally perturb the structure and function
of integral membrane proteins are needed. In this study, we genetically incor-
porated Anap, an environmentally-sensitive fluorescent unnatural amino acid,
into specific locations in the Arabidopsis thaliana type 2 Hþ-ATPase
(AHA2) expressed in Saccharomyces cerevisiae. The nonsense stop codon
TAG was substituted for Trp codons to incorporate the unnatural amino acid
into specific sites within the first two transmembrane alpha helices of AHA2
using an engineered suppressor tRNA that carries the artificial amino acid
and is orthogonal to natural amino acids. Culture conditions were varied to
maximize expression of a fluorescent 97 kDa protein in yeast that was only ob-
served when Anap was included in the culture media. By taking advantage of
the environmentally sensitive properties of this fluorescent unnatural amino
acid, the resultant labeled protein can be used to study conformational dynam-
ics during the enzyme cycle that may result from changes in the local environ-
ment surrounding the incorporated fluorescent probe. Fluorescence labeling of
membrane proteins using this approach should allow detailed studies of local
conformational kinetics that will shed new light on structure function relation-
ships in this class of enzymes.
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Juan Pablo F. Rossi, Irene C. Mangialavori, Ana Maria, Villamil Giraldo,
Maria F. Pignataro, Mariela S. Ferreira Gomes, Ariel J. Caride.
The exposure of plasma membrane calcium pump to surrounding phospho-
lipids was assessed by measuring the incorporation of the photoactivatable re-
agent [125I]TID-PC/16 into the membrane regions of this pump. In the absence
of activators, Ca2þ increases the incorporation of [125I]TID-PC/16. On the
contrary, in the presence of Ca2þ and either calmodulin or phosphatidic acid
the incorporation of the labeled phospholipids is decreased. Proteolysis of
PMCA with V8 protease results in 3 main fragments: fragment N (TM 1 and
2), fragment M (TM 3 and 4) and fragment C (TM 5 to 10). In the presence
of Ca2þ, CaM decreased the level of incorporation of [125I]TID-PC/16 to
fragments M and C, while phosphatidic acid decreased the incorporation of
[125I]TID-PC/16 to fragments N and M, suggesting that the conformational
changes induced by calmodulin or phosphatidic acid extend to the transmem-
brane domains. The result also indicates differences between the active confor-
mations produced by calmodulin and acidic phospholipids. To verify this, we
also measured FRET between PMCA labeled with eosin isothiocianate at the
ATP binding site and Rho-PE included in PMCA-containing micelles. CaM de-
creased the efficiency of the energy transfer between these two probes while PA
did not. The result indicates that activation by CaM increases the distance be-
tween the ATP binding site and the membrane, but acidic phospholipids do not.
Moreover, the access of two proteases to their sites of cleavage was different in
the presence of calmodulin or phosphatidic acid. The results indicate structural
differences between the PMCA conformations induced by these activators.
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Different Pathways for Association and Dissociation of the Calmodulin
Binding Domain of Plasma Membrane Calcium Pump Isoform 4b
John T. Penniston, Ariel J. Caride, Emanuel E. Strehler.
The calmodulin (CaM) binding domain of isoform 4b of the Plasma Mem-
brane Ca2þ Pump (PMCA4b) is represented by the peptide C28. CaM binds
to either PMCA or C28 by a mechanism in which the primary anchor residue
of the binding domain (Trp 1093) binds to the C-terminal lobe of the extended
CaM molecule, followed by collapse of CaM with the N-terminal lobe bind-
ing to the secondary anchor Phe 1110 (N Juranic et al. [2010] J Biol Chem
285:4015-4024). This is a relatively rapid reaction, with a half time of about
1 sec. The dissociation of CaM from PMCA4b or C28 is much slower, with
a half time of about 10 min. Fluorescence measurements with C28 and the
fluorescent CaM derivative TA-CaM, and molecular dynamics calculations
concur in showing that the path of release of the PMCA4b CaM binding do-
main is quite different from that of binding. We now show that in the presence
466a Tuesday, March 8, 2011of Ca2þ, dissociation of CaM from C28 occurs by a pathway in which Trp
1093, although deeply embedded in a pocket in the C-terminal lobe of
CaM, leaves first. The dissociation begins by relatively rapid release of Trp
1093, followed by very slow release of Phe 1110, removal of C28 and return
of CaM to its conformation in the free state. The intermediate of dissociation
with exposed Trp 1093 has a long lifetime (minutes), and is an activated form
of PMCA. This mechanism may explain some unique biological properties of
PMCA4b.
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Oligomeric Interactions of Sarcolipin and SERCA Detected by FRET
Microscopy
Joseph M. Autry, John E. Rubin, Seth L. Robia, David D. Thomas.
We have monitored molecular interactions of sarcolipin (SLN) and the sarco-
plasmic reticulum Ca- ATPase (SERCA) by measuring Fo¨rster resonance en-
ergy transfer (FRET) between fusion proteins labeled with cyan fluorescent
protein (donor) and yellow fluorescent protein (acceptor). SLN is a key mem-
brane protein that controls muscle contractility by regulating the calcium
transport activity of SERCA, and perhaps by also acting as an ATP-
activated anion channel (Becucci et al., Biophys. J. 2007, 2009). Here we
used baculovirus expression of fluorescent fusion proteins in insect cells
and FRET microscopy to provide novel evidence for (a) independent oligo-
merization of SLN and (b) regulatory complex formation between SERCA
and SLN. FRET assays demonstrated that SLN monomers self-assemble
into dimers and higher-order oligomers in the absence of SERCA, but that
SLN monomers also bind to SERCA in a 1:1 binary complex when the two
proteins are co-expressed. FRET assays further demonstrated that the binding
affinity of SLN:SLN homo-oligomers is greater than the binding affinity of
SERCA:SLN hetero-dimers, indicating that SLN monomers favor self-
association over SERCA binding. Mutating SLN residue isoleucine-17 to al-
anine (I17A) decreased FRET for SLN self-association and eliminated multi-
meric assembly of SLN, converting higher-order oligomers into monomers
and dimers. The I17A mutation also decreased FRET for SERCA:SLN
binding but maintained 1:1 stoichiometry of hetero-dimer formation. Thus,
isoleucine-17 is a residue that plays dual roles in (a) determining the distribu-
tion of SLN homo-oligomers and (b) stabilizing the formation of
SERCA:SLN hetero-dimers. When expressed in bacterial cells, wild-type
SLN prevented colony formation but the I17A-SLN mutant did not, indicating
that higher-order oligomers of SLN exhibit antibacterial activity, possibly
through channel formation. We propose that SLN exists as multiple molecular
species in muscle membranes, including SERCA-free (monomer, dimer, olig-
omer) and SERCA-bound (hetero-dimer).
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Identification of Phospholemman Residues Critical to Phospholemman
Oligomerization and Na Pump Association
Julie Bossuyt, Joseph C. Li, Mounir Khafaga, Linda L. Lee,
Luiza Mamikonian, Sanda Despa, Donald M. Bers.
Phospholemman (PLM or FXYD1) associates with and modulates Na pump
(NKA) function in a manner similar to phospholamban (PLB) regulation of
SERCA. That is, PLM inhibits NKA by reducing its [Na]i-affinity and PLM
phosphorylation relieves this inhibition. We have also shown that PLM forms
homo-oligomers (as does PLB) but it is unknown how PLM-PLM interactions
occur or what functional role PLM oligomers have. Here we use site-directed
mutagenesis and FRET to identify which PLM residues are critical to the
PLM-NKA and PLM-PLM association, respectively. We hypothesize that mu-
tations affecting PLM-PLM affinity will enhance PLM-NKA complexes and
display stronger NKA inhibition, and vice versa. Based on crystal NKA-
FXYD structure, the PLM sites G20, F28 & G31 were selected as potential
NKA interaction sites and I26, I29, L30, L33&L36 as putative PLM interac-
tion sites (analogous to leucine zippers thought to mediate PLB pentameriza-
tion). Alanine substitution of F28 eliminated PLM-NKA FRET (Fdonor
increase by only 0.254% vs 1852% for WT). Despite only minor effects
on PLM-NKA interaction for G31A (Fdonor increase by 1451%), its PLM-
PLM FRET was significantly increased (Fdonor increase by 5553% vs
3755% for WT). Alanine substitution of I26, L30 & L33 all significantly re-
duced PLM-PLM FRET (Fdonor increase by 1552%, 1353% and 2053% re-
spectively vs 3755% for WT) and opposing effects on PLM-NKA FRET
were observed (e.g. Fdonor increases by 3356% for L33A vs 1852% for
WT). We conclude that PLM homo-oligomers have a structural basis that par-
allels PLB (Leucine zipper). Moreover our hypothesis that altering the PLM
affinity for NKA also changes the interaction of PLM with other PLM mole-
cules (and vice versa) seems to be correct. Our data support the existence of
a dynamic equilibrium of PLM oligomers and PLM-NKA that exerts func-
tional regulation of NKA.2524-Pos Board B510
Highly Specific, Conformationally-Dependent Cross-Linking of Lys27 of
PLB to SERCA2a in Cardiac SR Vesicles from Humans
Brandy L. Akin, Larry R. Jones.
Phospholamban (PLB) inhibits SERCA2a, the Ca2þ-ATPase of cardiac sarco-
plasmic reticulum (SR), by decreasing the apparent Ca2þ affinity of the en-
zyme. The mechanism of Ca2þ pump inhibition by PLB has been studied by
our group using chemical cross-linking agents, which enable PLB-binding in-
teractions with SERCA2a to be measured simultaneously with enzyme inhibi-
tion. Previously, cross-linking of canine PLB to SERCA2a was only attainable
with Cys-scanning point mutants of PLB. For example, N27C of canine PLB
cross-links exclusively to Lys328 of canine SERCA2a with heterobifunctional
thiol-to-amine cross-linking agents after co-expression of the two proteins in
Sf21 insect cells. Here, we show with SR vesicles prepared from human hearts,
that PLB and SERCA2a are cross-linkable using DSG (disuccinimidyl gluta-
rate), a 7.7 A˚ long, homobifunctional, amine-specific cross-linking agent.
Cross-linking of human PLB to SERCA2a takes advantage of the unique Lys
residue at position 27 of human PLB, making it susceptible to amine-specific
cross-linkers without the need for mutagenesis. This was confirmed by testing
SR vesicles prepared from both human and canine ventricles; DSG cross-linked
human, but not canine, PLB to SERCA2a. Cross-linking of human PLB to
SERCA2a was completely inhibited by either Ca2þ (Ki = 0.50 mM), or the
Ca2þ pump inhibitor thapsigargin, but substantially augmented by ATP.
This is the first demonstration that PLB binds exclusively to the E2 conforma-
tion of SERCA2a in SR vesicles, preferentially the state with bound nucleotide
(E2$ATP), and not the state stabilized by thapsigargin (protonated E2). Impor-
tantly, similar results were obtained with SR vesicles prepared from both nor-
mal and failed human hearts, indicating that PLB-binding interactions with
SERCA2a are unchanged in failing myocardium. Studies are in progress to
demonstrate with human SR vesicles that Lys27 of PLB cross-links exclusively
to Lys328 of SERCA2a.
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Muscle contraction and relaxation are controlled through the release and reup-
take of Ca2þ stored in the sarcoplasmic reticulum (SR). Relaxation is mediated
by the SR Ca2þ ATPase (SERCA), a pump that drives Ca2þ against its concen-
tration gradient while hydrolyzing ATP. Cardiac SERCA is regulated by phos-
pholamban (PLB), a small membrane protein that inhibits the pump except
when phosphorylated at Ser16. PLB phosphorylation restores SERCA activity
without dissociating the two proteins, instead inducing a structural change
within the PLB-SERCA complex. Although a number of studies have investi-
gated the interaction of these proteins, the relationship between phosphoryla-
tion, structure, and activity remains unresolved. We have used dipolar
electron-electron resonance (DEER) spectroscopy, a technique capable of mea-
suring distances from 2-7nm, to characterize large conformational changes
within PLB upon phosphorylation and SERCA binding. Our results show
that the transmembrane and cytoplasmic helices of PLB draw closer upon
SERCA binding, with subsequent phosphorylation compacting the structure
still further. However, relative distances between the cytoplasmic domains of
PLB and SERCA remain largely constant before and after phosphorylation,
suggesting that the observed structural change occurs in the transmembrane do-
main of PLB. Ultimately, our goal is to make exhaustive distance measure-
ments within the SERCA-PLB complex in order to understand the structural
basis of phosphorylation-mediated inhibition relief.
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Ji Li, Christine Karim, David D. Thomas.
We used fluorescence to investigate the structure and dynamics of phospholam-
ban (PLB) and its inhibited target, sarcoplasmic reticulum Ca-ATPase
(SERCA). Time-resolved fluorescence energy transfer (TR-FRET) was used
to study the oligomeric interaction between PLB and SERCA. Previous work
on our lab has shown that PLB is primarily pentameric but SERCA binds pref-
erentially to the monomeric form in lipid vesicles. Recent EM studies suggest
that the PLB pentamer might also bind to SERCA.We tested this hypothesis by
labeling SERCA at C674 with a fluorescent donor (TMRIA) and labeling PLB
at K3 with a non-fluorescent acceptor (MGITC), then reconstituting the pro-
teins into lipid vesicles and performing TR-FRET as a function of the fraction
of acceptor-labeled PLB (xA), keeping the total PLB/SERCA molar ratio con-
stant at 10. Simulations showed that if a PLB monomer binds to SERCA, the
dependence of FRET on xA should be linear, but the binding of a PLB oligomer
